Sildenafil
Product Images NDC 50436-1210

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50436-1210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl504361210)

Label Image (Lbl504361210)
FDA Label Image

Figure-10 (Sildenafil Fig 10)

Figure-10 (Sildenafil Fig 10)
FDA Label Image

Figure-11 (Sildenafil Fig 11)

Figure-11 (Sildenafil Fig 11)
FDA Label Image

Fig-12 (Sildenafil Fig 12)

Fig-12 (Sildenafil Fig 12)
FDA Label Image

Fig-6 (Sildenafil Fig 6)

Fig-6 (Sildenafil Fig 6)
FDA Label Image

Fig-8 (Sildenafil Fig 8)

Fig-8 (Sildenafil Fig 8)
This appears to be a table showing various drugs and whether or not a dose adjustment is recommended when taken in conjunction with other drugs. The table also includes fold change and 90% confidence interval recommendations. The drugs listed include Conocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosint, Doxazosinz, Cnax, Ethinyloestradiol, Lovonorgestrel, Enprocoumon, Phenpr RS, Ritonavir, Saquinavir, Rolbutamide, and Tolbutamid. The last section of the table shows dosages for Doxazosin and Sildenafil alongside bleeding time and other information related to clinical studies.*
FDA Label Image

Figure-9 (Sildenafil Fig 9)

Figure-9 (Sildenafil Fig 9)
FDA Label Image

Figure-7 (Sildenafil Figure 7)

Figure-7 (Sildenafil Figure 7)
This is a drug interaction guide which outlines fold changes in the drug with %0% CI recommendations. The document provides information about various drugs such as Atorasttn, Astromycn UG, Bosentan, Cimetidine, Evermyel, beoanod c, Oral Contraceptives, and Saquinavie. The guide suggests that there is no need for a dose adjustment in most cases. The document also includes relative change in Sildenafil when taken with other drugs and provides a warning about a lack of benefit on exercise capacity when sildenafil is added to bosentan therapy.*
FDA Label Image

Str (Sildenafil Str)

Str (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.